QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
OTCMKTS:VBIO

Vitality Biopharma Stock Forecast, Price & News

$0.32
-0.05 (-13.51 %)
(As of 10/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.31
$0.36
50-Day Range
$0.20
$0.80
52-Week Range
$0.05
$0.85
Volume46,832 shs
Average Volume77,264 shs
Market Capitalization$16.38 million
P/E RatioN/A
Dividend YieldN/A
Beta3.83
30 days | 90 days | 365 days | Advanced Chart
Receive VBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for Vitality Biopharma and its competitors with MarketBeat's FREE daily newsletter.


Vitality Biopharma logo

About Vitality Biopharma

Malachite Innovations, Inc. engages in unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. It operates through Pharmaceutical Operations and Clinical Operations segments. The Clinical Operations segment focuses on treating patients suffering from addiction and dependency. The Pharmaceutical Operations segment engages in research and development primarily related to the Company's cannabinoid pharmaceuticals. The company was founded by Avtar S. Dhillon and Robert T. Brooke on June 29, 2007 and is headquartered in Los Angeles, CA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:VBIO
Previous Symbol
OTCMKTS:STVF
Employees
3
Year Founded
N/A

Sales & Book Value

Annual Sales
$260,000.00
Book Value
$0.02 per share

Profitability

Net Income
$-880,000.00

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$16.38 million
Next Earnings Date
11/12/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.07 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -












Vitality Biopharma (OTCMKTS:VBIO) Frequently Asked Questions

What stocks does MarketBeat like better than Vitality Biopharma?

Wall Street analysts have given Vitality Biopharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Vitality Biopharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Vitality Biopharma?

Vitality Biopharma saw a drop in short interest during the month of September. As of September 30th, there was short interest totaling 700 shares, a drop of 93.9% from the September 15th total of 11,400 shares. Based on an average daily volume of 233,300 shares, the short-interest ratio is currently 0.0 days.
View Vitality Biopharma's Short Interest
.

When is Vitality Biopharma's next earnings date?

Vitality Biopharma is scheduled to release its next quarterly earnings announcement on Friday, November 12th 2021.
View our earnings forecast for Vitality Biopharma
.

How were Vitality Biopharma's earnings last quarter?

Vitality Biopharma, Inc. (OTCMKTS:VBIO) released its quarterly earnings results on Friday, August, 13th. The company reported ($0.01) earnings per share (EPS) for the quarter.
View Vitality Biopharma's earnings history
.

How has Vitality Biopharma's stock price been impacted by Coronavirus (COVID-19)?

Vitality Biopharma's stock was trading at $0.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, VBIO stock has increased by 300.0% and is now trading at $0.32.
View which stocks have been most impacted by COVID-19
.

Who are Vitality Biopharma's key executives?

Vitality Biopharma's management team includes the following people:
  • Michael Cavanaugh, Chief Executive Officer & Director
  • Richard McKilligan, Controller, Chief Financial & Accounting Officer
  • Brandon Zipp, Chief Science Officer

What other stocks do shareholders of Vitality Biopharma own?

What is Vitality Biopharma's stock symbol?

Vitality Biopharma trades on the OTCMKTS under the ticker symbol "VBIO."

How do I buy shares of Vitality Biopharma?

Shares of VBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vitality Biopharma's stock price today?

One share of VBIO stock can currently be purchased for approximately $0.32.

How much money does Vitality Biopharma make?

Vitality Biopharma has a market capitalization of $16.38 million and generates $260,000.00 in revenue each year.

How many employees does Vitality Biopharma have?

Vitality Biopharma employs 3 workers across the globe.

What is Vitality Biopharma's official website?

The official website for Vitality Biopharma is www.vitality.bio.

Where are Vitality Biopharma's headquarters?

Vitality Biopharma is headquartered at 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067.

How can I contact Vitality Biopharma?

Vitality Biopharma's mailing address is 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067. The company can be reached via phone at (530) 231-7800 or via email at [email protected].


This page was last updated on 10/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.